Results 191 to 200 of about 236,238 (308)
Skin lesions in patients treated with growth hormone and those with growth hormone excess: a current overview. [PDF]
Matwiejuk M +4 more
europepmc +1 more source
Boron‐10 carriers and their applications in boron neutron capture therapy
Summary of different types of boron drugs. Abstract Boron neutron capture therapy (BNCT) has emerged as a promising therapeutic modality in cancer treatment, demonstrating the ability to selectively eliminate cancer cells through the 10B(n,α)7Li nuclear reaction with minimal side effects on normal tissues.
Dachao Tang +7 more
wiley +1 more source
Pituitary involvement in ANCA-associated vasculitis: Case report and literature review. [PDF]
Chen X +6 more
europepmc +1 more source
ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve +6 more
wiley +1 more source
Clinical evaluation of determinations of free and serum protein bound triiodthyronine (dextran gel filtration) [PDF]
Heinze, H. G. +3 more
core
Genes associated with genetic and rare lung diseases and the risk of lung cancer. [PDF]
Rosenberger A +33 more
europepmc +1 more source
Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)
ABSTRACT Ashwagandha is a widely used herb in traditional medicine systems, particularly Ayurveda. Despite its extensive tradition, growing concerns regarding its potential endocrinological effects have prompted scientific scrutiny. This review systematically evaluates the current preclinical, clinical, and case study evidence concerning AS's effects ...
Günter Vollmer, Thomas Brendler
wiley +1 more source
A modular analyzer system for the mechanization of double antibody radioimmunoassays. [PDF]
Erhardt, F. +3 more
core +1 more source

